Residents of Washington DC Can Also Get a Free HIV Test at the DMV

I don’t care what state one lives in, a visit to the long lines at the DMV is not anything one looks forward too, but now there’s something else to wait in line for in Washington DC and this is a free HIV test that has a wait of maybe 20 minutes to get the results too. In addition a $15.00 credit is given for the expenses at the DMV.

We are starting to see more medical type testing appearing in non conventional surroundings, such as K-Mart for an aneurism test.

Blue Light Special at K-Mart–Free Aneurysm Screenings at the Pharmacy Department September 20- November 5th

Gilead Sciences, a company that specializes in HIV drugs was responsible for making the grant possible. Below is a listing from their website of the HIV/AIDS drugs they have available. The company also has quite a few clinical trials in process, and some of those are outside the HIV/AIDS area to include a couple areas of heart disease. BD

Atripla® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) is the first and only once-daily single tablet regimen for the treatment of HIV infection in adults. It is intended for use as a stand-alone therapy, or in combination with other antiretrovirals, and combines Gilead's Truvada® (emtricitabine and tenofovir disoproxil fumarate) with Sustiva® (efavirenz), manufactured by Bristol-Myers Squibb. (U.S. approval, 2006; E.U. approval, 2007.)

Emtriva® (emtricitabine) is a once-daily oral nucleoside reverse transcriptase inhibitor (NRTI) used in combination with other antiretroviral agents for the treatment of HIV infection in adults. Emtriva is also available as an oral solution for use in pediatric patients. (U.S. and E.U. approval, 2003.)

Truvada® (emtricitabine and tenofovir disoproxil fumarate) is a fixed-dose once-daily combination pill containing Viread® and Emtriva®. It is used in combination with other antiretroviral agents for the treatment of HIV infection in adults. (U.S. approval, 2004; E.U. approval, 2005.)

Viread® (tenofovir disoproxil fumarate) is a once-daily oral nucleotide reverse transcriptase inhibitor (NtRTI) for the treatment of HIV infection in adults and adolescents in combination with other antiretroviral agents. (U.S. approval, 2001; E.U. approval, 2002.) Viread® was also approved in 2008 as a treatment for chronic hepatitis B in adults. (U.S. and EU approval, 2008.)

(CNN) -- Residents of the nation's capital can now get a driver's license and free HIV testing -- at the same time.

A Department of Motor Vehicles branch in southeast Washington is offering testing for the disease under a pilot program aimed at educating residents and reducing stigma.

"We realize that this is a nontraditional setting, but this program is about normalizing HIV and extending testing opportunities," said Angela Fulwood Wood, chief operations officer for nonprofit Family and Medical Counseling Service. "We chose the DMV because it offers a good cross-section of people."

Gilead Sciences, a California-based pharmaceutical company, provided a $250,000 grant to fund the program, according to Wood.

The first-day response was "excellent ... there has been a line waiting to get the HIV test," Vigilance said.

"Many people have to wait for some of the DMV services and the rapid HIV test takes only 20 minutes. It fits perfectly with the waiting times."

Residents can get tested for HIV as they wait for driver's license - CNN.com